# Keiran S.M. Smalley

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/keiran-s-m-smalley/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,412 |
| Field | Melanoma and MAPK Pathways |
| h-index | 64 |
| i10-index | 165 |
| Last Known Institution | Moffitt Cancer Center |
| OpenAlex ID | https://openalex.org/A5059758317 |
| ORCID iD | https://orcid.org/0000-0003-1089-9307 |
| Works | 548 |

## Researcher papers

- [PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression](https://scholariq.org/papers/pten-loss-confers-braf-inhibitor-resistance-to-melanoma-cells-through-the/)
- [Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy](https://scholariq.org/papers/recovery-of-phospho-erk-activity-allows-melanoma-cells-to-escape-from-braf/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Moffitt Cancer Center](https://scholariq.org/institutions/moffitt-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.